February 29, 2024
Regional media highlighted the University of Cincinnati Cancer Center being the first site in the Midwest enrolling patients in a new Phase 2 clinical trial testing a vaccine to treat pancreatic cancer.
February 20, 2024
The University of Cincinnati Cancer Center is the first site in the Midwest enrolling patients in a new Phase 2 clinical trial testing a vaccine to treat pancreatic cancer.
April 4, 2024
Clinical research conducted at the University of Cincinnati College of Medicine and UC Health played a role in the U.S. Food and Drug Administration's March 26 approval of WINREVAIR™ (sotatercept-csrk) for the treatment of pulmonary arterial hypertension (PAH) in adults.
May 8, 2024
The University of Cincinnati's Vince Martin spoke with South Bend television station WNDU on a recent study that found people who suffer from migraines might be able to predict when one is coming hours before symptoms even start.
May 2, 2024
The University of Cincinnati's Vincent Martin was featured in a New York Magazine/The Cut article discussing the lack of solid evidence that chocolate is a migraine trigger.
November 2, 2022
A collaborative research team at the University of Cincinnati has received a $3.5 million National Institutes of Health grant to examine how current HIV medications are affected by alcohol use alone or in combination with fentanyl.
August 10, 2022
University of Cincinnati researchers Jason Gardner and Matthew Robson are studying whether targeting an inflammation pathway that affects burns and traumatic brain injuries can be an effective treatment for both conditions.
March 29, 2023
University of Cincinnati research on the steroid dexamethasone's effect on immune cells and benefit to severe COVID-19 patients was recently published in Frontiers in Immunology.
April 25, 2023
An international multicenter study that was conducted at the University of Cincinnati was stopped early after research demonstrated that a daily statin medication reduced the risk of cardiovascular disease among people living with HIV.
January 18, 2023
Research from the University of Cincinnati shows people who wear tefillin, leather bands used in a Jewish religious practice which involves the tight wrapping of an arm with the bands, may receive cardiovascular health benefits. The study suggests those benefits are the result of ischemic or reduced blood flow preconditioning which produces protection from the damage caused by heart attacks.